The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma.

Autor: Estephan F; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA., Lap CJ; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA., Banagan J; Institute for Clinical Research, Washington, DC, USA., Antonio M; Institute for Clinical Research, Washington, DC, USA., Liu S; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, Washington, DC, USA., Diao G; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, Washington, DC, USA., Rozalen AZ; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA., Rajendran R; Institute for Clinical Research, Washington, DC, USA., Krasnow S; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA., Subrahmanyam R; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA., Nava VE; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA., Jain M; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC, USA. Electronic address: maneesh.jain@va.gov.

Publikováno v: Annals of diagnostic pathology [Ann Diagn Pathol] 2023 Dec; Vol. 67, pp. 152219. Date of Electronic Publication: 2023 Oct 20.

Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.

Autor: Mavingire, Nicole¹ (AUTHOR) nmavingire@msm.edu, Moore, Janelle C.¹ (AUTHOR) jcmoore@msm.edu, Johnson, Jabril R.² (AUTHOR) jabjohnson@msm.edu, Dwead, Abdulrahman M.¹ (AUTHOR), Cropp, Cheryl D.³ (AUTHOR) ccropp@msm.edu, Mechref, Yehia⁴ (AUTHOR), Kobeissy, Firas⁵ (AUTHOR) fkobaissy@msm.edu, Rais-Bahrami, Soroush^6,7,8 (AUTHOR) sraisbahrami@uabmc.edu, Woods-Burnham, Leanne¹ (AUTHOR) lburnham@msm.edu

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3262. 19p.

Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas.

Autor: Quaquarini, Erica¹ (AUTHOR) erica.quaquarini@gmail.com, Grillo, Federica² (AUTHOR) federica.grillo@unige.it, Gervaso, Lorenzo³ (AUTHOR) lorenzo.gervaso@ieo.it, Arpa, Giovanni^4,5 (AUTHOR) giovanni.arpa@icsmaugeri.it, Fazio, Nicola³ (AUTHOR) nicola.fazio@ieo.it, Vanoli, Alessandro^4,6 (AUTHOR) alessandro.vanoli@unipv.it, Parente, Paola⁷ (AUTHOR) paolaparente77@gmail.com

Publikováno v: Cancers. Sep2024, Vol. 16 Issue 18, p3145. 36p.

Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA.

Autor: Schumann C; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Nguyen DX; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Norgard M; Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, Oregon 97239, USA., Bortnyak Y; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Korzun T; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Chan S; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Lorenz AS; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Moses AS; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Albarqi HA; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Wong L; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Michaelis K; Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, Oregon 97239, USA., Zhu X; Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, Oregon 97239, USA., Alani AWG; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Taratula OR; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Krasnow S; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA., Marks DL; Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, Oregon 97239, USA., Taratula O; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA.

Publikováno v: Theranostics [Theranostics] 2018 Oct 22; Vol. 8 (19), pp. 5276-5288. Date of Electronic Publication: 2018 Oct 22 (Print Publication: 2018).

Review of the Use of Medicinal Cannabis Products in Palliative Care.

Autor: Troyer, James¹ (AUTHOR) jtroyer@mdanderson.org, Tanco, Kimberson¹ (AUTHOR) kctanco@mdanderson.org

Publikováno v: Cancers. Apr2024, Vol. 16 Issue 7, p1412. 13p.